Exicure, Inc.
Exicure, Inc. is listed today as Exicure, Inc.: market value, financials and filings are on its company page.
Funding rounds
1 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Aug 2018 | $22 M | No. 1 | $10 to $50 million | equity | SEC | |
| Sep 2017 | $43 M | Issued in a merger or acquisition | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
As the listed company Exicure, Inc., its revenue in fiscal 2024 came from these business segments: Biotechnology $500,000 (100%).
Annual report (SEC XBRL) · Dec 2024
Exicure, Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2018).
SEC Form D · Aug 2018
The industry group it chose in its notices: Biotechnology.
SEC Form D · Aug 2018
Products and services#
No products or services of Exicure, Inc. are on record.
Investors#
No investor of Exicure, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 39 investors.
Largest shareholders today
Institutions holding Exicure, Inc. shares, as of Sep 30, 2026.
- Citadel Advisors LLC$0 M1.35%
- Geode Capital Management, LLC$0 M0.63%
- Vanguard Capital Management LLC$0 M0.45%
- Two Sigma Investments, LP$0 M0.21%
- Virtu Financial LLC$0 M0.21%
- Vanguard Fiduciary Trust Co$0 M0.21%
- Tower Research Capital LLC (TRC)$0 M0.08%
- UBS Group AG$0 M0.05%
- SBI Securities Co., Ltd.$0 M0.00%
- Morgan Stanley$0 M0.00%
- Royal Bank Of Canada$0 M0.00%
- BlackRock, Inc.$0 M0.00%
- Osaic Holdings, Inc.$0 M0.00%
- Prestige Wealth Management Group LLC$0 M0.00%
- Harbour Investments, Inc.$0 M0.00%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| David A. Giljohann | Executive officer | Aug 2018 |
| David S. Snyder | Executive officer | Aug 2018 |
| Ekambar R. Kandimalla | Executive officer | Aug 2018 |
| Matthias R. Schroff | Executive officer | Aug 2018 |
| C. Shad Thaxton | Director | Aug 2018 |
| Chad Mirkin | Director | Aug 2018 |
| David A. Giljohann | Director | Aug 2018 |
| David R. Walt | Director | Aug 2018 |
| Helen S. Kim | Director | Aug 2018 |
| Jay R. Venkatesan | Director | Aug 2018 |
Went public since 2018. Its SEC number is that of a company listed on a stock exchange.